Intra‐subtype heterogeneity shapes treatment response in KMT2A ‐rearranged ALL across all age groups

Documenti analoghi

• IntegrateALL: An end‐to‐end RNA‐seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B‐precursor ALL
  di: Nadine Wolgast, et al.
  Pubblicazione: (2026)
• Next‐generation sequencing and high DNA input identify previously missed measurable residual disease in peripheral blood of B‐cell precursor acute lymphoblastic leukaemia
  di: Sonja Bendig, et al.
  Pubblicazione: (2024)
• Myeloid Neoplasms With a t(5;12)(q31;p13) and an Associated ETV6 :: ACSL6 Gene Fusion Are Diagnostically Challenging and Have a Poor Prognosis
  di: Bettina Balk, et al.
  Pubblicazione: (2026)
• The rearrangement partner and the presence of MYC mutations determine the outcome of patients with MYC and BCL6 rearrangements
  di: Anna Stengel, et al.
  Pubblicazione: (2026)
• Artificial intelligence for risk assessment and outcome prediction in malignant haematology
  di: Jan‐Niklas Eckardt, et al.
  Pubblicazione: (2025)